drugset / Trial / NCT05701800
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this first-in-human study is to evaluate the safety and immunogenicity of mRNA-1468.
Timeline
- Start
- 2023-01-23
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Shingrix | Vaccine | — | Intramuscular |
| Subject | mRNA-1468 | Vaccine | — | Intramuscular |